Hyundai Bioscience's antiviral for Dengue Fever to enter clinical trials in Brazil
PR Newswire Asia
· "Aiming to offer a Dengue antiviral treatment course in $100 price range"
· Hyundai Bioscience decides to conduct dengue..
· "Aiming to offer a Dengue antiviral treatment course in $100 price range"
· Hyundai Bioscience decides to conduct dengue..
*–Net New Home Orders Increased 12% Year-Over-Year to 1,814–
**–Backlog Units Increased 35% Year-Over-Year to..
*Q1 2024 revenue and non-IFRS adjusted EPS* above the high end of guidance ranges;
**2024 full-year outlook raised*(All..